Genomic Patent Exclusivity Tackled By NIH “Best Practices” Draft Guidance
This article was originally published in The Gray Sheet
Executive Summary
NIH is floating a three-page draft guidance on best practices for the licensing of genomic inventions
You may also be interested in...
NIH Genomics Licensing Policy Guidance Debated By Advocacy Groups
The National Institutes of Health expects to publish by year-end a "best practices" document for the licensing of genomic inventions
NIH Genomics Licensing Policy Guidance Debated By Advocacy Groups
The National Institutes of Health expects to publish by year-end a "best practices" document for the licensing of genomic inventions
Pharmacogenomic Progress Hinges On Strong Pharma Backing – Consultant
Reference labs developing less costly "homebrew" tests could supplant diagnostic firms as the vehicle for commercializing pharmacogenomic tests, consultant Richard Barker told attendees at the IBC Dx/Rx Summit March 9 in Reston, Va